Indian pharma industry’s big pivot: Report reveals sector transitioning from generics to innovation
The Indian pharmaceutical industry is witnessing a profound transformation, transitioning from a generics-oriented hub to an innovation-driven pharmaceutical economy, largely attributed to its prominent Contract Development and Manufacturing Organizations (CDMOs).…
Pharma sector targets $300 billion revenue
New Delhi: The Indian pharmaceutical sector has the potential to grow to the size of $300 billion by 2030 from the current $15 billion provided it accords high priority on…
